Aspen Aerogels, Inc. (ASPN) Stock Price & Analysis
Aspen Aerogels, Inc. (ASPN) closed at USD 5.4 on Thursday, October 15, 2026, up 4.65% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 5.16; the Oct 15, 2026 session ranged USD 4.93–5.41 on volume of 1,101,504 shares. Market capitalization is $448.14M, with a 52-week range of USD 2.3–8.64 (NYQ). Source: Nexqual, retrieved October 16, 2026 at 05:20 UTC.
Also available as compact Markdown for AI agents: nexqual.com/ASPN.md
Key facts (ASPN)
- Analysts: Hold (mean 2.67 on a 1–5 scale) (6 analysts), mean target USD 7.75 (range 5–10).
- Total return with dividends: 1Y -35.0% vs S&P 500 +18.1%; 5Y -89.1% vs S&P 500 +85.1%.
- Next earnings: 2026-11-05, EPS estimate USD -0.07, revenue estimate $72.1M.
Analysts (ASPN)
Consensus Hold (mean 2.67 on a 1–5 scale), 6 analysts; mean target USD 7.75 (low 5, high 10).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-11 | Barclays | Target raised | Underweight | $4 → $5 |
Total return (dividends reinvested) (ASPN)
| 1Y (from 2025-10-16) | 5Y (from 2021-10-11) | |
|---|---|---|
| Total return | -35.0% | -89.1% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -35.1% | -35.7% |
| Volatility (annualized) | 104.2% | 84.6% |
| Max drawdown | -69.8% (Oct 2025→Feb 2026) | -95.3% (Nov 2021→Dec 2025) |
Key Statistics (as of October 16, 2026 at 05:20 UTC)
| Price | USD 5.4 |
|---|---|
| Change | ▲ 4.65% (up) |
| Previous Close | USD 5.16 |
| Open | USD 5.07 |
| Day Range | USD 4.93 – 5.41 |
| 52-Week Range | USD 2.3 – 8.64 |
| Volume | 1,101,504 shares |
| Market Cap | $448.14M |
| Exchange | NYQ |
Technical Analysis (ASPN)
Nexqual's technical model rates ASPN "NEUTRAL" based on 3 bullish and 2 bearish signals across 127 daily candles, as of October 16, 2026 at 05:20 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 51.28 (neutral) |
| vs SMA50 | Above (USD 5.38) |
| MACD | 0.07 (positive) |
Analyst Ratings (ASPN)
Wall Street analysts rate ASPN "Hold" based on 6 analysts, with a mean price target of USD 7.75 (range USD 5–10), per Nexqual as of October 16, 2026 at 05:20 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 6 |
| Mean Target | USD 7.75 |
| High Target | USD 10 |
| Low Target | USD 5 |
| Buy / Hold / Sell | 4 / 1 / 1 |
Earnings (ASPN)
| Next Earnings Date | 2026-11-05 |
|---|---|
| EPS Estimate | USD -0.07 |
| Revenue Estimate | $72.07M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.22 vs est -0.2 ▼ miss |
| 2026-03-31 | USD -0.28 vs est -0.26 ▼ miss |
| 2025-12-31 | USD -0.34 vs est -0.22 ▼ miss |
| 2025-09-30 | USD -0.06 vs est -0 ▼ miss |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Financials & Fundamentals (ASPN)
| Total Revenue | $202.09M |
|---|---|
| Revenue Growth (latest quarter, YoY) | -36.10% |
| Gross Margin | +16.24% |
| Operating Margin | -29.20% |
| Profit Margin | -62.45% |
| ROE | -50.36% |
| Debt / Equity | 0.65 |
| Current Ratio | 2.52 |
| Total Cash | $151.71M |
| Total Debt | $125.11M |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Financial Health Score (ASPN)
Nexqual rates Aspen Aerogels, Inc.'s overall financial health "Weak" across five dimensions, as of October 16, 2026 at 05:20 UTC.
| Growth | Critical — Revenue -40% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Gross margin 16%, operating -29% |
| Balance Sheet | Strong — $152M cash vs $125M debt, net cash position |
| Cash Flow | Solid — Operating cash flow $49M (TTM) |
| Efficiency | Critical — ROE -50%, ROA -8.4% |
Ownership (ASPN)
| Insider Ownership | +1.40% |
|---|---|
| Institutional Ownership | +74.42% |
| Shares Outstanding | 82.99M |
| Float | 76.70M |
| Short % of Float | +8.69% |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Leadership (ASPN)
Aspen Aerogels, Inc. is led by Donald R. Young (age 68), President, CEO & Director, per Nexqual as of October 16, 2026 at 05:20 UTC.
| President, CEO & Director | Donald R. Young (age 68) |
|---|---|
| CFO, Treasurer & Principal Financial and Accounting Officer | Grant D. Thoele (age 37) |
| Chief Operating Officer | Gregg R. Landes (age 55) |
| Senior Director of Corporate of Strategy & Finance | Neal Baranosky |
| Managing Director of Investment Banking at RBC Capital Markets Inc. | Paul Betts |
Major Backers & Investors (ASPN)
Notable institutional backers of Aspen Aerogels, Inc. include Kim, LLC , Oaktop Capital Management II, L.P., American Century Companies Inc, according to Nexqual as of October 16, 2026 at 05:20 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Kim, LLC | 14.8% |
| Oaktop Capital Management II, L.P. | 6.23% |
| American Century Companies Inc | 5.55% |
| Needham Investment Management, L.L.C. | 3.93% |
| George Kaiser Family Foundation | 3.82% |
| Needham Funds Inc-Needham Aggressive Growth Fund | 2.5% |
| Jacobs Levy Equity Management, Inc. | 2.48% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 8.45% |
| Vanguard Group | 8.42% |
| State Street | 4.37% |
Source: Nexqual, October 16, 2026 at 05:20 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CLMT | Calumet, Inc | USD 58.24 | ▼ 0.6% |
| BCPC | Balchem Corporation | USD 170.53 | ▲ 0.48% |
| SXT | Sensient Technologies Corporati | USD 133.42 | ▲ 0.66% |
| AXTA | Axalta Coating Systems Ltd. | USD 33.73 | ▲ 0.6% |
| EMN | Eastman Chemical Company | USD 63.87 | ▲ 1.38% |
| WLK | Westlake Corporation | USD 63.61 | ▲ 2.83% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 16, 2026 at 05:20 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt